Bioventus (NasdaqGS:BVS) FY Conference Transcript

Bioventus (NasdaqGS:BVS) FY Conference December 03, 2025 10:10 AM ET Company ParticipantsAnna Runci - Equity Research AssociateRob Claypoole - CEOAnna RunciPerfect.All right. Good morning, everyone. My name is Ana Runcie. I'm one of the associates on the med tech team here at Piper Sandler, and I'm very excited to introduce Rob Claypoole here, CEO of Bioventus, who's going to walk you through a brief presentation of the business. So I don't want to take up any more of your time. I will turn it over to you, ...